Literature DB >> 15188843

Eradication of a large outbreak of a single strain of vanB vancomycin-resistant Enterococcus faecium at a major Australian teaching hospital.

Keryn J Christiansen1, Patricia A Tibbett, William Beresford, John W Pearman, Rosie C Lee, Geoffrey W Coombs, Ian D Kay, Frances G O'Brien, Silvano Palladino, Charles R Douglas, Philip D Montgomery, Terri Orrell, Allison M Peterson, Frank P Kosaras, James P Flexman, Christopher H Heath, Cheryll A McCullough.   

Abstract

OBJECTIVE: To demonstrate that nosocomial transmission of vancomycin-resistant enterococci (VRE) can be terminated and endemicity prevented despite widespread dissemination of an epidemic strain in a large tertiary-care referral hospital.
INTERVENTIONS: Two months after the index case was detected in the intensive care unit, 68 patients became either infected or colonized with an epidemic strain of vanB vancomycin-resistant Enterococcus faecium despite standard infection control procedures. The following additional interventions were then introduced to control the outbreak: (1) formation of a VRE executive group; (2) rapid laboratory identification (30 to 48 hours) using culture and polymerase chain reaction detection of vanA and vanB resistance genes; (3) mass screening of all hospitalized patients with isolation of carriers and cohorting of contacts; (4) environmental screening and increased cleaning; (5) electronic flagging of medical records of contacts; and (6) antibiotic restrictions (third-generation cephalosporins and vancomycin).
RESULTS: A total of 19,658 patient and 24,396 environmental swabs were processed between July and December 2001. One hundred sixty-nine patients in 23 wards were colonized with a single strain of vanB vancomycin-resistant E. faecium. Introducing additional control measures rapidly brought the outbreak under control. Hospital-wide screening found 39 previously unidentified colonized patients, with only 7 more nonsegregated patients being detected in the next 2 months. The outbreak was terminated within 3 months at a cost of dollar 2.7 million (Australian dollars).
CONCLUSION: Despite widespread dissemination of VRE in a large acute care facility, eradication was achievable by a well-resourced, coordinated, multifaceted approach and was in accordance with good clinical governance.

Entities:  

Mesh:

Year:  2004        PMID: 15188843     DOI: 10.1086/502410

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  17 in total

1.  VanE-type vancomycin-resistant Enterococcus faecalis clinical isolates from Australia.

Authors:  Lorena Abadía-Patiño; Keryn Christiansen; Jan Bell; Patrice Courvalin; Bruno Périchon
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

2.  Clonal spread of a vancomycin-resistant Enterococcus faecium strain among bloodstream-infecting isolates in Italy.

Authors:  Lucia Stampone; Maria Del Grosso; Delia Boccia; Annalisa Pantosti
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

3.  Low vancomycin MICs and fecal densities reduce the sensitivity of screening methods for vancomycin resistance in Enterococci.

Authors:  Thamara M Wijesuriya; Peta Perry; Todd Pryce; John Boehm; Ian Kay; James Flexman; Geoffrey W Coombs; Paul R Ingram
Journal:  J Clin Microbiol       Date:  2014-05-28       Impact factor: 5.948

Review 4.  Integrated Multilevel Surveillance of the World's Infecting Microbes and Their Resistance to Antimicrobial Agents.

Authors:  Thomas F O'Brien; John Stelling
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

5.  Global spread of the hyl(Efm) colonization-virulence gene in megaplasmids of the Enterococcus faecium CC17 polyclonal subcluster.

Authors:  Ana R Freitas; Ana P Tedim; Carla Novais; Patricia Ruiz-Garbajosa; Guido Werner; Jenny A Laverde-Gomez; Rafael Cantón; Luísa Peixe; Fernando Baquero; Teresa M Coque
Journal:  Antimicrob Agents Chemother       Date:  2010-04-12       Impact factor: 5.191

6.  Molecular epidemiology of enterococcal bacteremia in Australia.

Authors:  Geoffrey W Coombs; Julie C Pearson; Denise A Daley; Tam Le; Owen J Robinson; Thomas Gottlieb; Benjamin P Howden; Paul D R Johnson; Catherine M Bennett; Timothy P Stinear; John D Turnidge
Journal:  J Clin Microbiol       Date:  2014-01-03       Impact factor: 5.948

7.  Outbreak of vancomycin-resistant enterococcus colonization among pediatric oncology patients.

Authors:  Sheila M Nolan; Jeffrey S Gerber; Theoklis Zaoutis; Priya Prasad; Susan Rettig; Kimberly Gross; Karin L McGowan; Anne F Reilly; Susan E Coffin
Journal:  Infect Control Hosp Epidemiol       Date:  2009-04       Impact factor: 3.254

8.  Epidemiology and control of an outbreak of vancomycin-resistant enterococci in the intensive care units.

Authors:  Young Kyung Yoon; Hee Sun Sim; Jeong Yeon Kim; Dae Won Park; Jang Wook Sohn; Kyung Ho Roh; Seung Eun Lee; Min Ja Kim
Journal:  Yonsei Med J       Date:  2009-10-21       Impact factor: 2.759

9.  Vancomycin-resistant Enterococcus faecium COLONIZATION and Clostridium difficile infection in a HEMATOLOGIC patient.

Authors:  Ivana Goić-Barišić; Marina Radić; Anita Novak; Žana Rubić; Nataša Boban; Boris Lukšić; Marija Tonkić
Journal:  Acta Clin Croat       Date:  2020-09       Impact factor: 0.780

10.  Beyond the bundle--journey of a tertiary care medical intensive care unit to zero central line-associated bloodstream infections.

Authors:  Matthew C Exline; Naeem A Ali; Nancy Zikri; Julie E Mangino; Kelly Torrence; Brenda Vermillion; Jamie St Clair; Mark E Lustberg; Preeti Pancholi; Madhuri M Sopirala
Journal:  Crit Care       Date:  2013-03-04       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.